YU41170B - Process for preparing 1,2,3,5-tetra-hydro-imidazotieno-pyrimidin-2-ones - Google Patents

Process for preparing 1,2,3,5-tetra-hydro-imidazotieno-pyrimidin-2-ones

Info

Publication number
YU41170B
YU41170B YU1947/79A YU194779A YU41170B YU 41170 B YU41170 B YU 41170B YU 1947/79 A YU1947/79 A YU 1947/79A YU 194779 A YU194779 A YU 194779A YU 41170 B YU41170 B YU 41170B
Authority
YU
Yugoslavia
Prior art keywords
imidazotieno
pyrimidin
hydro
tetra
ones
Prior art date
Application number
YU1947/79A
Other languages
English (en)
Other versions
YU194779A (en
Inventor
F Ishikawa
S Ashida
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of YU194779A publication Critical patent/YU194779A/xx
Publication of YU41170B publication Critical patent/YU41170B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU1947/79A 1978-08-11 1979-08-10 Process for preparing 1,2,3,5-tetra-hydro-imidazotieno-pyrimidin-2-ones YU41170B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9783278A JPS5527105A (en) 1978-08-11 1978-08-11 Imidazothienopyrimidinones compound

Publications (2)

Publication Number Publication Date
YU194779A YU194779A (en) 1983-10-31
YU41170B true YU41170B (en) 1986-12-31

Family

ID=14202683

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1947/79A YU41170B (en) 1978-08-11 1979-08-10 Process for preparing 1,2,3,5-tetra-hydro-imidazotieno-pyrimidin-2-ones

Country Status (16)

Country Link
US (1) US4284773A (fr)
EP (1) EP0008408B1 (fr)
JP (1) JPS5527105A (fr)
AU (1) AU529068B2 (fr)
CA (1) CA1116597A (fr)
CS (1) CS219256B2 (fr)
DE (1) DE2961552D1 (fr)
DK (1) DK153844C (fr)
ES (1) ES483289A1 (fr)
GR (1) GR73839B (fr)
IL (1) IL57923A (fr)
MX (1) MX6242E (fr)
PH (1) PH15530A (fr)
SU (1) SU880252A3 (fr)
YU (1) YU41170B (fr)
ZA (1) ZA793909B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287340A (en) * 1979-08-27 1981-09-01 Warner-Lambert Company Dihydro-oxo-pyrido[1,2-a]thienopyrimidine compounds
CA1142924A (fr) * 1980-06-27 1983-03-15 Hoffmann-La Roche Limited Derives de pyrimidine
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
CA3089569C (fr) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0808950D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
EP2321341B1 (fr) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
EP2970384A1 (fr) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
WO2015021358A2 (fr) 2013-08-09 2015-02-12 Dominique Charmot Composés et procédés d'inhibition du transport de phosphate
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890321A (en) * 1971-09-20 1975-06-17 Pfizer 6-aryl-5-ethyl-pyrimidin-4-ol compounds useful as intermediates and bronchodilators
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
DE2411273A1 (de) * 1974-03-06 1975-09-18 Schering Ag Neue thieno eckige klammer auf 2,3-d eckige klammer zu pyrimidinone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPS5527105A (en) 1980-02-27
AU4973579A (en) 1980-02-14
SU880252A3 (ru) 1981-11-07
US4284773A (en) 1981-08-18
MX6242E (es) 1985-01-28
DK153844B (da) 1988-09-12
DE2961552D1 (en) 1982-02-04
JPS627914B2 (fr) 1987-02-19
PH15530A (en) 1983-02-09
CA1116597A (fr) 1982-01-19
GR73839B (fr) 1984-05-04
AU529068B2 (en) 1983-05-26
DK153844C (da) 1989-01-30
EP0008408A1 (fr) 1980-03-05
DK336779A (da) 1980-02-12
IL57923A (en) 1982-09-30
EP0008408B1 (fr) 1981-12-09
ZA793909B (en) 1980-10-29
YU194779A (en) 1983-10-31
CS219256B2 (en) 1983-03-25
ES483289A1 (es) 1980-09-01
IL57923A0 (en) 1979-11-30

Similar Documents

Publication Publication Date Title
YU42193B (en) Process for preparing 1,8-naphthydrine compound
YU289180A (en) Process for preparing alfa-aryl-1h-1,2,4-triazole-1-ethanols
YU43116B (en) Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
GB2017687B (en) Process for preparing 2,2,6,6,-tetramethyl-4-piperidone
YU41170B (en) Process for preparing 1,2,3,5-tetra-hydro-imidazotieno-pyrimidin-2-ones
PT70486A (en) Process for preparing 1,2,4,5-tetra-alkyl-4-arylpiperidines
PT70340A (en) Process for preparing 3,4-dihydro-3-oxo-2-quinoxalines
YU78679A (en) Process for obtaining 1,3-dibenzoyloxy-17 alpha-ethinyl-7 alpha-methyl-1,3,5(10)-estratriene-17 beta-ol
DE3070919D1 (en) Process for preparing 1,3,7-trialkylxanthines
DE2967250D1 (en) Process for preparing 2,3,5,6-tetrachloropyridine
SU913942A3 (en) Process for producing 2,4-diamino-6-pyperidinopyrimidine-3-oxy (its modifications)
YU298779A (en) Process for preparing 2,6-dialkyl-n-alkoxymethyl-2-chloroacetanilides
DE2961058D1 (en) Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides
DE2960047D1 (en) Process for preparing 2-oximinophenylacetonitrile
YU55679A (en) Process for obtaining 1,2-dioximes
GB2015517B (en) Process for producing 3,5-dichloro- - methylstyrene
YU298180A (en) Process for preparing 5,10-dihydroimidazo-2,1-quinazoline
HU175923B (en) Process for preparing 1,6-di-o-methanesulphonyl-3,4-di-o-methyl-d-mannitol
YU216479A (en) Process for obtaining 5,6,2-methyl-n-phenyl-1,4-oxathiine-3-carboxamide
YU40759B (en) Process for obtaining 1,2,3-thiadiazole-5-yl-carbamide
PT69540A (en) Process for preparing 1,4-bis-piperonylpiperazine and similar compounds
GB2026489B (en) Process for obtaining 1,5-dinitro-anthraquinone
DE2960290D1 (en) Process for preparing 2,5-dichloro-4-cyanophenol
IL57980A0 (en) Method for preparing 7,8-dichloro-tetra-hydroisoquinoline
DE2960679D1 (en) D-homosteroids, process for their preparation